JOSEPH HARWOOD: Open Payments
NPI 1154070068 · MACON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$406 in 10 payments from 6 companies in 2025. Trend: 2023 $17 · 2024 $394 · 2025 $406
Food & beverage: $406
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 5 | $203 |
| Alkermes, Inc. | 1 | $120 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $26 |
| Vanda Pharmaceuticals Inc. | 1 | $24 |
| Janssen Pharmaceuticals, Inc | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
Products named: ABILIFY MAINTENA, ARISTADA, ABILIFY ASIMTUFII, CAPLYTA, FANAPT, INVEGA SUSTENNA, UZEDY.
Industry payments across GA — which companies pay providers there.
